Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial of Deep Neuromuscular Blockade Reversed With Sugammadex Versus Moderate Neuromuscular Block Reversed With Neostigmine, on Postoperative Quality of Recovery

NCT03034577 is registered in ClinicalTrials.gov with University of Melbourne as lead sponsor.

NCT NCT03034577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03034577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial of Deep Neuromuscular Blockade Reversed With Sugammadex Versus Moderate Neuromuscular Block Reversed With Neostigmine, on Postoperative Quality of Recovery
Lead sponsor
University of Melbourne
Phase
Phase 4
Overall status
Completed
Start date
June 16, 2017
Completion date
April 1, 2019
Enrollment
350 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia recovery period, laparoscopy